Saturday 17 October 2026
Export LONA’s income statement to Excel — free account
LeonaBio, Inc.
LONA Healthcare Biotechnology
In the quarter to June 2026, EPS grew 55.6% and free cash flow fell 142.3%, each against the same quarter a year earlier.
5.20
0.09
−1.70%
Follow LONA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(89.42%) | (290.81%) | (298.76%) | (431.39%) | |
| (64.88%) | (139.94%) | (224.87%) | (306.05%) | ||
ROIC |
(1,573.20%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(145.35%) | (243.19%) | (202.92%) | (294.67%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(13.27) | (10.69) | (2.73) | (2.61) | |
Free Cash Flow |
(52.34) | (45.73) | (51.97) | (61.93) | |
| Other line items | |||||
Cash ROIC |
(100.64%) | (39.38%) | (44.42%) | (73.14%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.39 | 0.43 | 0.40 | 0.44 | |
Depreciation/Fixed assets |
0.40 | 0.44 | 0.35 | 0.31 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(13.27) | (10.69) | (2.73) | (2.61) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates